These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24582665)

  • 21. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
    N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
    Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels.
    Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
    J Biol Chem; 2006 Feb; 281(5):3006-12. PubMed ID: 16332676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism.
    Taneja TK; Mankouri J; Karnik R; Kannan S; Smith AJ; Munsey T; Christesen HB; Beech DJ; Sivaprasadarao A
    Hum Mol Genet; 2009 Jul; 18(13):2400-13. PubMed ID: 19357197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
    Tammaro P; Proks P; Ashcroft FM
    J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
    Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
    J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment.
    Slingerland AS; Hattersley AT
    Ann Med; 2005; 37(3):186-95. PubMed ID: 16019717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
    Lin YW; Bushman JD; Yan FF; Haidar S; MacMullen C; Ganguly A; Stanley CA; Shyng SL
    J Biol Chem; 2008 Apr; 283(14):9146-56. PubMed ID: 18250167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2.
    Deacon RM; Brook RC; Meyer D; Haeckel O; Ashcroft FM; Miki T; Seino S; Liss B
    Physiol Behav; 2006 Apr; 87(4):723-33. PubMed ID: 16530794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
    Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
    Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
    Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
    Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2.
    Bahi-Buisson N; Eisermann M; Nivot S; Bellanné-Chantelot C; Dulac O; Bach N; Plouin P; Chiron C; de Lonlay P
    J Child Neurol; 2007 Sep; 22(9):1147-50. PubMed ID: 17890419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gain-of-function mutations in the K(ATP) channel (KCNJ11) impair coordinated hand-eye tracking.
    McTaggart JS; Jenkinson N; Brittain JS; Greeley SA; Hattersley AT; Ashcroft FM
    PLoS One; 2013; 8(4):e62646. PubMed ID: 23626843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
    Hattersley AT; Ashcroft FM
    Diabetes; 2005 Sep; 54(9):2503-13. PubMed ID: 16123337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice.
    Görtz N; Lewejohann L; Tomm M; Ambrée O; Keyvani K; Paulus W; Sachser N
    Behav Brain Res; 2008 Aug; 191(1):43-8. PubMed ID: 18433890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
    Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
    Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P; Girard C; Ashcroft FM
    Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.